October 2011 
Volume 41  Number 10
Pages 24 - 24
  PDF Version Available!

A new study has found that women age 70 or older with a history of heart disease and/or diabetes who take trastuzumab for breast cancer have an increased risk of developing asymptomatic or symptomatic cardiotoxicity.Forty-five patients, ages 70 to 92, who were taking trastuzumab since 2005 were identified. Thirty-three percent of women with cardiovascular risk factors such as heart disease or diabetes developed cardiotoxicity, compared with 9.1% of women who didn't have a history of heart disease and 6.1% of those without diabetes. The study authors advise close monitoring of these patients to avoid complications.Source: Serrano C, Cortes J, De Mattos-Aruda L, et al. Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. Ann Oncol. 2011 Aug 9. [E-pub ahead of print].The FDA has approved oral fidaxomicin for the treatment of C. difficile-associated diarrhea (CDAD). Besides causing diarrhea, C. difficile can lead to colitis and other serious gastrointestinal

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events